Digital Health

AppWorks

Check: Not publicly disclosed for Beacon Funds commitments. AppWorks' direct-company strategy publishes US$200K to US$15M per deal from Seed through Series C; that range should not be applied to Jun's venture-fund investments.

Jun uses fund investments as ecosystem infrastructure: back locally connected or specialist managers, exchange market intelligence and diligence, create co-investment and follow-on capital paths, and help portfolio companies enter new Asian markets. In direct opportunities, his writing favors repeat founders with learned resilience, large problems native to Southeast Asia, sound unit economics, profitability and margin discipline, and teams able to adapt when the original model fails.

Craft Ventures

Check: No personal check-size range is published. Craft invests from angel/seed through venture and growth; amounts in Bryan's investment announcements are total company rounds, not his personal or standard Craft checks.

Bryan applies a growth, revenue, and marketplace lens shaped by building Reddit's New York revenue organization and Twitter's startup advertising business. His investments favor products that remove expensive operational friction, demonstrate clear founder-market fit, delight customers enough to produce strong advocacy, and can use software, AI, services, or community-led distribution to create a meaningful performance advantage.

Khosla Ventures

Check: No personal check range is published. Khosla's Seed Fund supports science and business-model experiments, historically often with roughly $1M–$2M according to a 2020 firm interview, while its Main Fund covers early through later stages. These are firm-level references, not Alex's authority.

Alex invests where computation, biology, and healthcare converge. His scientific and clinical background supports a systems view of biomarker discovery, therapeutics, diagnostics, personalized medicine, neurotechnology, connected devices, and AI-enabled care. He favors important health outcomes and technologies that can automate expensive or inconsistent processes, increase access, and create reproducible, lower-cost care—not science detached from delivery and economics.

BoxGroup

Check: No reliable Arielle-specific check size is public. BoxGroup describes itself as an earliest-stage investor, but founders should confirm current round fit and allocation directly rather than relying on third-party range estimates.

Arielle invests within BoxGroup's broad earliest-stage mandate. Her differentiated documented context is technical and translational: Harvard bioengineering research, founding a postpartum medical-device project, product work in fertility AI and neuromodulation, mechanical engineering at a bioelectronic-medicine startup, and consulting at BCG. This supports a credible ability to evaluate user need, clinical workflow, product design, manufacturing, regulatory planning and commercialization in technical health businesses. It does not establish an exclusive healthcare mandate or a personally published investment thesis.

AirTree Ventures (Web3)

Check: Neither Airtree nor Jackie publishes her personal check range or decision authority. The firm is seed-first and supports companies through later stages; individual portfolio round totals do not reveal Airtree's allocation or Jackie's authority.

Jackie backs Australia and New Zealand founders from very early product formation through scale. Her disclosed portfolio crosses AI and enterprise software, healthcare, fintech, consumer platforms, future-of-work tools, commerce, and purpose-led brands. Her investment notes repeatedly test market size and structural change, founder intensity and fit, customer love, defensible unit economics, resilience, and the ability to convert an initial wedge into a global company.

Big Pi Ventures

Check: Growth-fund level: Big Pi Growth I states that it leads with €7M–€20M+ per company. Big Pi's overall platform spans €0.5M–€30M across funds. Neither range is published as Fanis's personal allocation authority.

Fanis supports European technology scale-ups moving toward market leadership with growth capital plus operational and financial expertise. His background in TMT investment banking and as FlexCar's finance leader supports a value-creation lens centered on financing structure, valuation, capital efficiency, international expansion, organic growth, and selective M&A rather than capital alone.

Northzone (Web3)

Check: Not publicly disclosed. Northzone states that the firm invests from Seed through Growth and can remain a partner through pre-IPO; Wendy's current profile labels her personal focus as Early and says she likes to work with founders from as early as seed.

Wendy backs companies that change consumer behavior and expand the economic pie by capturing neglected externalities. She studies technology through people and behavior change, looking for a valuable position in a shifting value chain and a product capable of profound systemic change. Her hypothesis-led process separates factual and emotional evidence, makes assumptions explicit, challenges them through diligence, and still requires a differentiated leap of faith about fund-returning potential.

Big Pi Ventures

Check: Growth-fund level: Big Pi Growth I states that it leads with €7M–€20M+ per company. Panos focuses on Series B+ growth investments; the published fund range is not a guarantee of his personal allocation authority for any deal.

Panos leads growth investments in European technology companies that already show category leadership and can use €7M–€20M+ plus active operating support to scale internationally. His recent work emphasizes InfraTech and Physical AI at the intersection of innovative technology and real infrastructure, where proprietary systems, strong customer ROI, global deployments, and Southeast European operating hubs can create durable scale advantages.

GreyMatter

Check: GreyMatter does not publish a standard current check-size range on its official site.

Natalie Bartlett invests or supports investments through GreyMatter's published strategy: Back early founders transforming mental health through better access, outcomes, infrastructure, science and experiences.

BoxGroup

Check: BoxGroup publicly invests up to $1M. Older third-party profiles place Adina's typical early-stage range around $250K–$500K, but founders should treat the firm's current $1M ceiling—not an old personal range—as authoritative.

Adina is an early-stage generalist with a publicly documented emphasis on B2B software, consumer internet, and fintech. Her operating background in e-commerce and recent visible interest in AI deployment and software agents point to companies that convert new technical capability into practical workflows. She invests within BoxGroup's people-first formation-stage model, prioritizing founder-market fit and category potential over polished early metrics.

BoxGroup

Check: BoxGroup publicly invests up to $1M. Some third-party directories show an older $250K–$500K personal range, but no current primary source confirms a separate personal allocation.

Claire backs formation-stage technology companies as a BoxGroup generalist, with visible strength across enterprise and developer software, AI-native products, consumer experiences, and marketplaces. Her operating and investing background supports a product-and-distribution lens: founders should pair a distinctive experience with a credible route to repeated use and category leadership, even when the company is still pre-product or pre-traction.

BoxGroup

Check: BoxGroup publicly invests up to $1M. Third-party profiles estimate Disha's range at $500K–$1M, but no primary source confirms a personal range, so the firm ceiling is the safer planning assumption.

Disha invests at the earliest stages with a differentiated mix of finance, neuroscience, biotech R&D, and prior growth-investing exposure. Her public investor profile points to AI, enterprise infrastructure and software, digital and consumer health, biotech, and commerce. Within BoxGroup's generalist model, the through-line is an exceptional founder using technical or domain insight to create a category, not a rigid sector checklist.

First Round Capital

Check: Firm-level: First Round says initial investments typically range from $1M-$7M, average about $3.5M, and have ranged below and above that; participating rounds have ranged from $100K-$20M.

Roy spends most of his First Round time in healthcare, applying three decades of product, innovation, and care-delivery experience to companies that can materially improve lives. He favors practical experimentation and measurable implementation over technology theater: identify a consequential workflow, build with the private context and orchestration required for accuracy, rigorously test real outcomes, and help founders win early customers, prioritize development, refine sales, hire, and learn faster.

HealthX Ventures

Check: HealthX Ventures does not publish a standard check-size range on its current official website.

Alexis Johnson contributes to HealthX Ventures's published strategy: Lead seed equity rounds in scalable digital-health companies and actively help with healthcare customers, teams, operations and syndicates.

HealthX Ventures

Check: HealthX Ventures does not publish a standard check-size range on its current official website.

Kayla Liederbach contributes to HealthX Ventures's published strategy: Lead seed equity rounds in scalable digital-health companies and actively help with healthcare customers, teams, operations and syndicates.

HealthX Ventures

Check: HealthX Ventures does not publish a standard check-size range on its current official website.

Emma Merrick contributes to HealthX Ventures's published strategy: Lead seed equity rounds in scalable digital-health companies and actively help with healthcare customers, teams, operations and syndicates.

HealthX Ventures

Check: HealthX Ventures does not publish a standard check-size range on its current official website.

Dan Neill contributes to HealthX Ventures's published strategy: Lead seed equity rounds in scalable digital-health companies and actively help with healthcare customers, teams, operations and syndicates.

Tau Ventures

Check: Tau Ventures does not publish a standard current check-size range on its live official site.

Sam Bogrov invests or supports investments through Tau Ventures's published strategy: Partner early with founders applying AI to healthcare, enterprise workflows, automation and frontier technologies, with selective support through growth.

Tau Ventures

Check: Tau Ventures does not publish a standard current check-size range on its live official site.

Amit Garg invests or supports investments through Tau Ventures's published strategy: Partner early with founders applying AI to healthcare, enterprise workflows, automation and frontier technologies, with selective support through growth.

Tau Ventures

Check: Tau Ventures does not publish a standard current check-size range on its live official site.

Sanjay Rao invests or supports investments through Tau Ventures's published strategy: Partner early with founders applying AI to healthcare, enterprise workflows, automation and frontier technologies, with selective support through growth.

Tau Ventures

Check: Tau Ventures does not publish a standard current check-size range on its live official site.

Insoo Chang invests or supports investments through Tau Ventures's published strategy: Partner early with founders applying AI to healthcare, enterprise workflows, automation and frontier technologies, with selective support through growth.

Tau Ventures

Check: Tau Ventures does not publish a standard current check-size range on its live official site.

Sharon Huang invests or supports investments through Tau Ventures's published strategy: Partner early with founders applying AI to healthcare, enterprise workflows, automation and frontier technologies, with selective support through growth.

Tau Ventures

Check: Tau Ventures does not publish a standard current check-size range on its live official site.

Gary Ang invests or supports investments through Tau Ventures's published strategy: Partner early with founders applying AI to healthcare, enterprise workflows, automation and frontier technologies, with selective support through growth.

Tau Ventures

Check: Tau Ventures does not publish a standard current check-size range on its live official site.

Larry Augustin invests or supports investments through Tau Ventures's published strategy: Partner early with founders applying AI to healthcare, enterprise workflows, automation and frontier technologies, with selective support through growth.

Tau Ventures

Check: Tau Ventures does not publish a standard current check-size range on its live official site.

Ravi Varma invests or supports investments through Tau Ventures's published strategy: Partner early with founders applying AI to healthcare, enterprise workflows, automation and frontier technologies, with selective support through growth.

Tau Ventures

Check: Tau Ventures does not publish a standard current check-size range on its live official site.

Sonal Panda is listed in a Advisory Partner capacity at Tau Ventures. No person-specific investment thesis is published for this role; the firm's mandate is included only as shared context.

Clarevia

Check: Clarevia does not publish a standard current check-size range on its official site.

Jim Adox invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from therapeutic and device innovation to new care solutions.

Clarevia

Check: Clarevia does not publish a standard current check-size range on its official site.

Scott Button invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from therapeutic and device innovation to new care solutions.

Clarevia

Check: Clarevia does not publish a standard current check-size range on its official site.

Paul Weiss invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from therapeutic and device innovation to new care solutions.

Clarevia

Check: Clarevia does not publish a standard current check-size range on its official site.

David Arnstein is listed in a Partner and Chief Financial Officer capacity at Clarevia. No person-specific investment thesis is published for this role; the firm's mandate is included only as shared context.

Clarevia

Check: Clarevia does not publish a standard current check-size range on its official site.

John Neis invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from therapeutic and device innovation to new care solutions.

Clarevia

Check: Clarevia does not publish a standard current check-size range on its official site.

Joe Amaral, MD is listed in a Chief Medical and Scientific Officer capacity at Clarevia. No person-specific investment thesis is published for this role; the firm's mandate is included only as shared context.

Clarevia

Check: Clarevia does not publish a standard current check-size range on its official site.

Jenni Le invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from therapeutic and device innovation to new care solutions.

Clarevia

Check: Clarevia does not publish a standard current check-size range on its official site.

Margaret Kaczor Andrew invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from therapeutic and device innovation to new care solutions.

Clarevia

Check: Clarevia does not publish a standard current check-size range on its official site.

Cheryl R. Blanchard, PhD invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from therapeutic and device innovation to new care solutions.

Clarevia

Check: Clarevia does not publish a standard current check-size range on its official site.

Shelly Lanning invests or supports investments through Clarevia's published strategy: Back visionary healthcare entrepreneurs and breakthrough ideas that can improve patient lives, from therapeutic and device innovation to new care solutions.

Clarevia

Check: Clarevia does not publish a standard current check-size range on its official site.

Becky Hoerman is listed in a Controller capacity at Clarevia. No person-specific investment thesis is published for this role; the firm's mandate is included only as shared context.

Clarevia

Check: Clarevia does not publish a standard current check-size range on its official site.

Linda Olson is listed in a Office Manager capacity at Clarevia. No person-specific investment thesis is published for this role; the firm's mandate is included only as shared context.

GreyMatter

Check: GreyMatter does not publish a standard current check-size range on its official site.

Danish Munir invests or supports investments through GreyMatter's published strategy: Back early founders transforming mental health through better access, outcomes, infrastructure, science and experiences.

GreyMatter

Check: GreyMatter does not publish a standard current check-size range on its official site.

Anna Wang invests or supports investments through GreyMatter's published strategy: Back early founders transforming mental health through better access, outcomes, infrastructure, science and experiences.

GreyMatter

Check: GreyMatter does not publish a standard current check-size range on its official site.

Andrew Barr invests or supports investments through GreyMatter's published strategy: Back early founders transforming mental health through better access, outcomes, infrastructure, science and experiences.

7wire Ventures

Check: 7wire Ventures does not publish a standard current check-size range on its official site.

David Schonthal is listed in a Operating Partner capacity at 7wire Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

7wire Ventures

Check: 7wire Ventures does not publish a standard current check-size range on its official site.

Tom Richards is listed in a Operating Partner capacity at 7wire Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

7wire Ventures

Check: 7wire Ventures does not publish a standard current check-size range on its official site.

Cameron Raglin invests or supports investments through 7wire Ventures's published strategy: Build and back early-stage digital-health companies that give informed, connected consumers more control and improve healthcare quality, access, outcomes and cost.

7wire Ventures

Check: 7wire Ventures does not publish a standard current check-size range on its official site.

Joslin Owens is listed in a Director of Finance capacity at 7wire Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

7wire Ventures

Check: 7wire Ventures does not publish a standard current check-size range on its official site.

Sathya Shanthakumar is listed in a Director of Investor Relations capacity at 7wire Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

Bow Capital

Check: $5M average investment into core companies, as published by Bow Capital.

Vivek Ranadivé is listed in a Founder and Managing Director capacity at Bow Capital. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

Bow Capital

Check: $5M average investment into core companies, as published by Bow Capital.

Murray Rode invests or supports investments through Bow Capital's published strategy: Back founders building AI for the physical world across modern industry, defense, logistics and digital biology, using the University of California ecosystem to accelerate science into society.

Define Ventures

Check: Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.

Lynne Chou O'Keefe invests or supports investments through Define Ventures's published strategy: Back category-defining healthcare companies that combine deep ecosystem understanding with a technology-driven mindset across enterprise, value-based care and consumer health.

Define Ventures

Check: Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.

Bruce Broussard invests or supports investments through Define Ventures's published strategy: Back category-defining healthcare companies that combine deep ecosystem understanding with a technology-driven mindset across enterprise, value-based care and consumer health.

Define Ventures

Check: Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.

Frank Williams invests or supports investments through Define Ventures's published strategy: Back category-defining healthcare companies that combine deep ecosystem understanding with a technology-driven mindset across enterprise, value-based care and consumer health.

Define Ventures

Check: Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.

Carolyn Magill invests or supports investments through Define Ventures's published strategy: Back category-defining healthcare companies that combine deep ecosystem understanding with a technology-driven mindset across enterprise, value-based care and consumer health.

Define Ventures

Check: Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.

Karsten Vagner is listed in a Head of People capacity at Define Ventures. This profile preserves that functional distinction; the firm's investment mandate is included only as shared context.

Define Ventures

Check: Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.

Shannon Knous is listed in a VP of Finance & Operations capacity at Define Ventures. This profile preserves that functional distinction; the firm's investment mandate is included only as shared context.

Define Ventures

Check: Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.

Lauren O'Mahony is listed in a Head of Marketing capacity at Define Ventures. This profile preserves that functional distinction; the firm's investment mandate is included only as shared context.

Define Ventures

Check: Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.

Katharine Morris is listed in a Administrative Assistant & Office Manager capacity at Define Ventures. This profile preserves that functional distinction; the firm's investment mandate is included only as shared context.

Boomerang Ventures

Check: Boomerang Ventures does not publish a standard current check-size range on its official site.

Alex Shandiz invests or supports investments through Boomerang Ventures's published strategy: Build and invest in connected-health companies improving care quality, access, delivery, efficiency and patient experience, with particular attention to Midwest opportunities.

Boomerang Ventures

Check: Boomerang Ventures does not publish a standard current check-size range on its official site.

Ariel MacTavish invests or supports investments through Boomerang Ventures's published strategy: Build and invest in connected-health companies improving care quality, access, delivery, efficiency and patient experience, with particular attention to Midwest opportunities.

Boomerang Ventures

Check: Boomerang Ventures does not publish a standard current check-size range on its official site.

Audrey Beckman invests or supports investments through Boomerang Ventures's published strategy: Build and invest in connected-health companies improving care quality, access, delivery, efficiency and patient experience, with particular attention to Midwest opportunities.

Boomerang Ventures

Check: Boomerang Ventures does not publish a standard current check-size range on its official site.

Dick Aderman is listed in a Studio Director capacity at Boomerang Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

Boomerang Ventures

Check: Boomerang Ventures does not publish a standard current check-size range on its official site.

Oscar Moralez invests or supports investments through Boomerang Ventures's published strategy: Build and invest in connected-health companies improving care quality, access, delivery, efficiency and patient experience, with particular attention to Midwest opportunities.

Boomerang Ventures

Check: Boomerang Ventures does not publish a standard current check-size range on its official site.

Todd R. Lugar is listed in a Controller and HR Lead capacity at Boomerang Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

Boomerang Ventures

Check: Boomerang Ventures does not publish a standard current check-size range on its official site.

Tony Petrucciani is listed in a Partner and Chief Financial Officer capacity at Boomerang Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

Tamarind Hill

Check: $2M-$7M seed rounds, as published by Tamarind Hill.

Ben Trumbull invests or supports investments through Tamarind Hill's published strategy: Lead seed rounds for B2B healthcare companies with early product-market fit across decentralized care, care economics and healthcare supply-chain innovation.

Tamarind Hill

Check: $2M-$7M seed rounds, as published by Tamarind Hill.

Josh Buehler invests or supports investments through Tamarind Hill's published strategy: Lead seed rounds for B2B healthcare companies with early product-market fit across decentralized care, care economics and healthcare supply-chain innovation.

Tamarind Hill

Check: $2M-$7M seed rounds, as published by Tamarind Hill.

Christie Currie invests or supports investments through Tamarind Hill's published strategy: Lead seed rounds for B2B healthcare companies with early product-market fit across decentralized care, care economics and healthcare supply-chain innovation.

Tamarind Hill

Check: $2M-$7M seed rounds, as published by Tamarind Hill.

Allison Weiland is listed in a Finance and Operations Manager capacity at Tamarind Hill. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

OCA Ventures

Check: $1M-$3M with follow-on capacity, as published by OCA Ventures.

Bob Saunders invests or supports investments through OCA Ventures's published strategy: Invest in U.S. and Canadian companies with dramatic growth potential, launched products and measurable early customer adoption.

OCA Ventures

Check: $1M-$3M with follow-on capacity, as published by OCA Ventures.

Nick Schoewe invests or supports investments through OCA Ventures's published strategy: Invest in U.S. and Canadian companies with dramatic growth potential, launched products and measurable early customer adoption.

OCA Ventures

Check: $1M-$3M with follow-on capacity, as published by OCA Ventures.

Kevin McQuillan invests or supports investments through OCA Ventures's published strategy: Invest in U.S. and Canadian companies with dramatic growth potential, launched products and measurable early customer adoption.

OCA Ventures

Check: $1M-$3M with follow-on capacity, as published by OCA Ventures.

Fahad Qureshi is listed in a Vice President, Accounting and Finance capacity at OCA Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

OCA Ventures

Check: $1M-$3M with follow-on capacity, as published by OCA Ventures.

Michelle Cao invests or supports investments through OCA Ventures's published strategy: Invest in U.S. and Canadian companies with dramatic growth potential, launched products and measurable early customer adoption.

OCA Ventures

Check: $1M-$3M with follow-on capacity, as published by OCA Ventures.

Manu Sharma invests or supports investments through OCA Ventures's published strategy: Invest in U.S. and Canadian companies with dramatic growth potential, launched products and measurable early customer adoption.

OCA Ventures

Check: $1M-$3M with follow-on capacity, as published by OCA Ventures.

Kelley Quinn is listed in a Finance and Operations Manager capacity at OCA Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

OCA Ventures

Check: $1M-$3M with follow-on capacity, as published by OCA Ventures.

Waverly Deutsch invests or supports investments through OCA Ventures's published strategy: Invest in U.S. and Canadian companies with dramatic growth potential, launched products and measurable early customer adoption.

OCA Ventures

Check: $1M-$3M with follow-on capacity, as published by OCA Ventures.

Peter Ianlo invests or supports investments through OCA Ventures's published strategy: Invest in U.S. and Canadian companies with dramatic growth potential, launched products and measurable early customer adoption.

OCA Ventures

Check: $1M-$3M with follow-on capacity, as published by OCA Ventures.

Sarah Manasevit invests or supports investments through OCA Ventures's published strategy: Invest in U.S. and Canadian companies with dramatic growth potential, launched products and measurable early customer adoption.

OCA Ventures

Check: $1M-$3M with follow-on capacity, as published by OCA Ventures.

Leticia Martinez is listed in a Senior Executive Assistant capacity at OCA Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

Mutual Capital Partners

Check: Mutual Capital Partners does not publish a standard current check-size range on its official site.

Bill Trainor invests or supports investments through Mutual Capital Partners's published strategy: Partner with healthcare IT and medical-device companies outside major technology centers that have strong teams, reference customers, meaningful revenue and attractive margins.

Mutual Capital Partners

Check: Mutual Capital Partners does not publish a standard current check-size range on its official site.

Wayne Wallace invests or supports investments through Mutual Capital Partners's published strategy: Partner with healthcare IT and medical-device companies outside major technology centers that have strong teams, reference customers, meaningful revenue and attractive margins.

Boomerang Ventures

Check: Boomerang Ventures does not publish a standard current check-size range on its official site.

Ally Thill is listed in a Project Leader capacity at Boomerang Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

OCA Ventures

Check: $1M-$3M with follow-on capacity, as published by OCA Ventures.

Ian Drury invests or supports investments through OCA Ventures's published strategy: Invest in U.S. and Canadian companies with dramatic growth potential, launched products and measurable early customer adoption.

Boomerang Ventures

Check: Boomerang Ventures does not publish a standard current check-size range on its official site.

Dan Clark invests or supports investments through Boomerang Ventures's published strategy: Build and invest in connected-health companies improving care quality, access, delivery, efficiency and patient experience, with particular attention to Midwest opportunities.

Boomerang Ventures

Check: Boomerang Ventures does not publish a standard current check-size range on its official site.

David Helmer invests or supports investments through Boomerang Ventures's published strategy: Build and invest in connected-health companies improving care quality, access, delivery, efficiency and patient experience, with particular attention to Midwest opportunities.

Boomerang Ventures

Check: Boomerang Ventures does not publish a standard current check-size range on its official site.

Eric Beier invests or supports investments through Boomerang Ventures's published strategy: Build and invest in connected-health companies improving care quality, access, delivery, efficiency and patient experience, with particular attention to Midwest opportunities.

Boomerang Ventures

Check: Boomerang Ventures does not publish a standard current check-size range on its official site.

Tejas Vijh invests or supports investments through Boomerang Ventures's published strategy: Build and invest in connected-health companies improving care quality, access, delivery, efficiency and patient experience, with particular attention to Midwest opportunities.

Tamarind Hill

Check: $2M-$7M seed rounds, as published by Tamarind Hill.

Mark Shary invests or supports investments through Tamarind Hill's published strategy: Lead seed rounds for B2B healthcare companies with early product-market fit across decentralized care, care economics and healthcare supply-chain innovation.

OCA Ventures

Check: $1M-$3M with follow-on capacity, as published by OCA Ventures.

Jim Dugan invests or supports investments through OCA Ventures's published strategy: Invest in U.S. and Canadian companies with dramatic growth potential, launched products and measurable early customer adoption.

OCA Ventures

Check: $1M-$3M with follow-on capacity, as published by OCA Ventures.

Steve Shein invests or supports investments through OCA Ventures's published strategy: Invest in U.S. and Canadian companies with dramatic growth potential, launched products and measurable early customer adoption.

OCA Ventures

Check: $1M-$3M with follow-on capacity, as published by OCA Ventures.

John Dugan invests or supports investments through OCA Ventures's published strategy: Invest in U.S. and Canadian companies with dramatic growth potential, launched products and measurable early customer adoption.

OCA Ventures

Check: $1M-$3M with follow-on capacity, as published by OCA Ventures.

Dave Zyer invests or supports investments through OCA Ventures's published strategy: Invest in U.S. and Canadian companies with dramatic growth potential, launched products and measurable early customer adoption.

OCA Ventures

Check: $1M-$3M with follow-on capacity, as published by OCA Ventures.

John Barnard invests or supports investments through OCA Ventures's published strategy: Invest in U.S. and Canadian companies with dramatic growth potential, launched products and measurable early customer adoption.

OCA Ventures

Check: $1M-$3M with follow-on capacity, as published by OCA Ventures.

Rashika Rahman invests or supports investments through OCA Ventures's published strategy: Invest in U.S. and Canadian companies with dramatic growth potential, launched products and measurable early customer adoption.

Mutual Capital Partners

Check: Mutual Capital Partners does not publish a standard current check-size range on its official site.

Liz Todia Zambory invests or supports investments through Mutual Capital Partners's published strategy: Partner with healthcare IT and medical-device companies outside major technology centers that have strong teams, reference customers, meaningful revenue and attractive margins.

Mutual Capital Partners

Check: Mutual Capital Partners does not publish a standard current check-size range on its official site.

Will Brune invests or supports investments through Mutual Capital Partners's published strategy: Partner with healthcare IT and medical-device companies outside major technology centers that have strong teams, reference customers, meaningful revenue and attractive margins.

HealthX Ventures

Check: HealthX Ventures does not publish a standard check-size range on its current official website.

Mark Bakken contributes to HealthX Ventures's published strategy: Lead seed equity rounds in scalable digital-health companies and actively help with healthcare customers, teams, operations and syndicates.

HealthX Ventures

Check: HealthX Ventures does not publish a standard check-size range on its current official website.

Samantha McGrandy contributes to HealthX Ventures's published strategy: Lead seed equity rounds in scalable digital-health companies and actively help with healthcare customers, teams, operations and syndicates.

HealthX Ventures

Check: HealthX Ventures does not publish a standard check-size range on its current official website.

Darcey Nett contributes to HealthX Ventures's published strategy: Lead seed equity rounds in scalable digital-health companies and actively help with healthcare customers, teams, operations and syndicates.

HealthX Ventures

Check: HealthX Ventures does not publish a standard check-size range on its current official website.

Brian Lindstrom contributes to HealthX Ventures's published strategy: Lead seed equity rounds in scalable digital-health companies and actively help with healthcare customers, teams, operations and syndicates.

HealthX Ventures

Check: HealthX Ventures does not publish a standard check-size range on its current official website.

Laura Hilty contributes to HealthX Ventures's published strategy: Lead seed equity rounds in scalable digital-health companies and actively help with healthcare customers, teams, operations and syndicates.

HealthX Ventures

Check: HealthX Ventures does not publish a standard check-size range on its current official website.

Shannon Flaherty contributes to HealthX Ventures's published strategy: Lead seed equity rounds in scalable digital-health companies and actively help with healthcare customers, teams, operations and syndicates.

Khosla Ventures

Check: No reliable current personal check range was found. Khosla Ventures invests across company stages and is known for both early technical risk and later follow-on support, but founders should ask Jun about the applicable vehicle, initial ownership, reserves and decision process rather than relying on marketplace estimates.

Jun backs long-horizon technologies at the intersection of biology, healthcare and frontier engineering. His medical training, decade of bench and clinical research, digital-health operating work and company-formation experience support a first-principles lens: take technically difficult risks where a validated breakthrough could materially improve health, then confront clinical evidence, affordability, access, regulation and real-world adoption early.

Khosla Ventures

Check: Not publicly disclosed. Khosla Ventures uses a Seed Fund for experiments and a Main Fund for early-to-later rounds, including financings above $10M in total round size; round size is not the firm's or Hari's check size.

Hari invests where technology can advance intelligence, security, infrastructure, and health. His founder/operator experience gives him a practical lens on regulated healthcare distribution, enterprise partnerships, product, and scaling. Within Khosla's broader approach, this means early, bold experiments aimed at large technology-disruptable markets, with a proprietary advantage and a low-cost plan to retire the most important technical and commercial risks.

PEN Ventures

Check: PEN Ventures does not publish a partner-specific or firm check-size range on its current website.

Steven brings accelerator, corporate innovation and venture experience across Southeast Asia, Australia/New Zealand and Korea. His disclosed investing track record includes 45 fintech and digital-health startups through Startupbootcamp programs, plus accelerators, a seed fund and a seed-stage company at SGInnovate.

7wire Ventures

Check: 7wire Ventures does not publish a standard current check-size range on its official site.

Glen Tullman invests or supports investments through 7wire Ventures's published strategy: Build and back early-stage digital-health companies that give informed, connected consumers more control and improve healthcare quality, access, outcomes and cost.

7wire Ventures

Check: 7wire Ventures does not publish a standard current check-size range on its official site.

Lee Shapiro invests or supports investments through 7wire Ventures's published strategy: Build and back early-stage digital-health companies that give informed, connected consumers more control and improve healthcare quality, access, outcomes and cost.

7wire Ventures

Check: 7wire Ventures does not publish a standard current check-size range on its official site.

Robert Garber invests or supports investments through 7wire Ventures's published strategy: Build and back early-stage digital-health companies that give informed, connected consumers more control and improve healthcare quality, access, outcomes and cost.

7wire Ventures

Check: 7wire Ventures does not publish a standard current check-size range on its official site.

Alyssa Jaffee invests or supports investments through 7wire Ventures's published strategy: Build and back early-stage digital-health companies that give informed, connected consumers more control and improve healthcare quality, access, outcomes and cost.

Define Ventures

Check: Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.

Chuka Esiobu invests or supports investments through Define Ventures's published strategy: Back category-defining healthcare companies that combine deep ecosystem understanding with a technology-driven mindset across enterprise, value-based care and consumer health.

Define Ventures

Check: Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.

Garrett Howard invests or supports investments through Define Ventures's published strategy: Back category-defining healthcare companies that combine deep ecosystem understanding with a technology-driven mindset across enterprise, value-based care and consumer health.

Bow Capital

Check: $5M average investment into core companies, as published by Bow Capital.

Manveer Sandhu invests or supports investments through Bow Capital's published strategy: Back founders building AI for the physical world across modern industry, defense, logistics and digital biology, using the University of California ecosystem to accelerate science into society.

Rock Health Capital

Check: Rock Health Capital does not publish a standard current check-size range on its official site.

Bill Evans invests or supports investments through Rock Health Capital's published strategy: Invest in remarkable entrepreneurs working at the intersection of healthcare and technology to make healthcare massively better for every human being.

Rock Health Capital

Check: Rock Health Capital does not publish a standard current check-size range on its official site.

Hylton Kalvaria is listed in a Advisor capacity at Rock Health Capital. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

Rock Health Capital

Check: Rock Health Capital does not publish a standard current check-size range on its official site.

Keith W. Anderson is listed in a Advisor capacity at Rock Health Capital. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

Rock Health Capital

Check: Rock Health Capital does not publish a standard current check-size range on its official site.

Monique Smith is listed in a Advisor capacity at Rock Health Capital. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

7wire Ventures

Check: 7wire Ventures does not publish a standard current check-size range on its official site.

Anish Aitharaju invests or supports investments through 7wire Ventures's published strategy: Build and back early-stage digital-health companies that give informed, connected consumers more control and improve healthcare quality, access, outcomes and cost.

Big Pi Ventures

Check: €0.5M-€30M across Big Pi's family of funds, from seed and early stage through growth; this is a firm-level range.

Guy brings a founder-operator lens to Big Pi's multi-stage technology strategy. He is best matched with technically differentiated companies that can turn defensible IP into global products, especially where AI, software, or automation can create a durable competitive advantage and where his experience scaling businesses across many markets is useful.

Define Ventures

Check: Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.

Erin Hardy is listed in a Accounting & Operations Manager capacity at Define Ventures. This profile preserves that functional distinction; the firm's investment mandate is included only as shared context.

Define Ventures

Check: Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.

Chirag Shah invests or supports investments through Define Ventures's published strategy: Back category-defining healthcare companies that combine deep ecosystem understanding with a technology-driven mindset across enterprise, value-based care and consumer health.

Define Ventures

Check: Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.

Michael Wert invests or supports investments through Define Ventures's published strategy: Back category-defining healthcare companies that combine deep ecosystem understanding with a technology-driven mindset across enterprise, value-based care and consumer health.

Bow Capital

Check: $5M average investment into core companies, as published by Bow Capital.

Rafi Syed invests or supports investments through Bow Capital's published strategy: Back founders building AI for the physical world across modern industry, defense, logistics and digital biology, using the University of California ecosystem to accelerate science into society.

Define Ventures

Check: Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.

Hong Truong invests or supports investments through Define Ventures's published strategy: Back category-defining healthcare companies that combine deep ecosystem understanding with a technology-driven mindset across enterprise, value-based care and consumer health.

Bow Capital

Check: $5M average investment into core companies, as published by Bow Capital.

Daven Patel invests or supports investments through Bow Capital's published strategy: Back founders building AI for the physical world across modern industry, defense, logistics and digital biology, using the University of California ecosystem to accelerate science into society.

Bow Capital

Check: $5M average investment into core companies, as published by Bow Capital.

Andre Ranadivé invests or supports investments through Bow Capital's published strategy: Back founders building AI for the physical world across modern industry, defense, logistics and digital biology, using the University of California ecosystem to accelerate science into society.

7wire Ventures

Check: 7wire Ventures does not publish a standard current check-size range on its official site.

Tiffany Yu invests or supports investments through 7wire Ventures's published strategy: Build and back early-stage digital-health companies that give informed, connected consumers more control and improve healthcare quality, access, outcomes and cost.

Rock Health Capital

Check: Rock Health Capital does not publish a standard current check-size range on its official site.

Sean Day invests or supports investments through Rock Health Capital's published strategy: Invest in remarkable entrepreneurs working at the intersection of healthcare and technology to make healthcare massively better for every human being.

Bow Capital

Check: $5M average investment into core companies, as published by Bow Capital.

Ian Walker invests or supports investments through Bow Capital's published strategy: Back founders building AI for the physical world across modern industry, defense, logistics and digital biology, using the University of California ecosystem to accelerate science into society.

7wire Ventures

Check: 7wire Ventures does not publish a standard current check-size range on its official site.

Eric Shan invests or supports investments through 7wire Ventures's published strategy: Build and back early-stage digital-health companies that give informed, connected consumers more control and improve healthcare quality, access, outcomes and cost.

Bow Capital

Check: $5M average investment into core companies, as published by Bow Capital.

James Chan is listed in a CFO capacity at Bow Capital. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

OCA Ventures

Chicago, Illinois

Define Ventures

Silicon Valley, California

7wire Ventures

Chicago, Illinois

Boomerang Ventures

Indianapolis, Indiana

Clarevia

Madison, Wisconsin

HealthX Ventures

Madison, Wisconsin

Tau Ventures

Palo Alto, California

AUM: $85M+ AUM disclosed on the firm's archived official site

Bow Capital

Menlo Park, California

Mutual Capital Partners

Westlake, Ohio

Rock Health Capital

San Francisco, California

Tamarind Hill

Dublin, Ohio

GreyMatter

United States